Related Experiment Video
Updated: May 27, 2026
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato1, Mizue Terai, Yutaka Tamura
1Department of Medical Oncology, Jefferson Medical College of Thomas Jefferson University, 1015 Walnut Street, Suite 1024 Curtis Building, Philadelphia, PA 19107, USA. takami.sato@jefferson.edu
Immunologic Research
|December 6, 2011
Summary
Interleukin-10 (IL-10) promotes cancer by suppressing immune responses. Blocking IL-10 alongside cancer vaccines or other immune stimulants may enhance antitumor immunity.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- Interleukin-10 (IL-10) is an immunomodulatory cytokine often found at high levels in cancer.
- IL-10 plays a complex role in cancer, potentially promoting tumor growth and metastasis.
- Elevated serum IL-10 correlates with disease progression, highlighting its significance in the tumor microenvironment.
Purpose of the Study:
- To elucidate the role of IL-10 in cancer immunology.
- To explore the mechanisms by which IL-10 contributes to immune suppression in cancer.
- To propose therapeutic strategies for enhancing antitumor immune responses by targeting IL-10.
Main Methods:
- Review of existing literature on IL-10 function in cancer.
- Analysis of IL-10's effects on antigen-presenting cells (APCs) and T cell responses.
- Evaluation of potential combination therapies involving IL-10 antagonism.
Main Results:
- IL-10 inhibits the function of antigen-presenting cells by reducing MHC and costimulatory molecule expression.
- IL-10 induces immune suppression and tolerance by downregulating Th1 cytokines and promoting T-regulatory responses.
- IL-10 is implicated in the progression of advanced metastases.
Conclusions:
- IL-10 is a key mediator of immune suppression within the tumor microenvironment.
- Targeting IL-10 offers a potential strategy to overcome cancer-induced immune evasion.
- Combining IL-10 antagonism with immunostimulatory agents like cancer vaccines or TLR agonists may enhance antitumor immunity.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...